Moss Genomics Launches "Perennial" Genomics Platform, Closes on 130 ETH
Summary
Perennial, which had been in beta testing since March, represents the Companys next step toward unlocking consumer-facing, data-driven health insights. In consideration for the acquisition of 130 ETH, the Company issued 2,527,777 common shares.This financing further supports Mosss strategic Ethereum treasury, which plays a central role in how the Company raises capital and manages its digital assets.All securities issued under the private placement are subject to a statutory hold period expiring four months plus one day from the date of issuance.The securities issued under the private placement have not been and will not be registered under the U.S. Securities Act and may not be offered or sold in the United States, or to, or for the account or benefit of, U.S. persons or persons in the United States, absent registration or an applicable exemption from the registration requirements.Moss Genomics is a biotechnology company focused on genomics and microbiome research to develop advanced genetic insights and solutions. Along with its genomics-focused products, Moss Genomics deploys a crypto accumulation strategy as part of its treasury management, currently holding 290 ETH on its balance sheet.For further information concerning Moss and its business, please view the Companys website at https://mossgenomics.com/ and its SEDAR+ profile at www.sedarplus.ca or contact us at:The CSE has neither approved nor disapproved the contents of this news release. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.The Company would like to remind investors that markets for cryptocurrencies have experienced much larger fluctuations than other markets, and there can be no assurances that significant swings in price will slow in the future. Any of these events may adversely affect the operations of the Company and, consequently, its business and profitability.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/249949